Home Gilead stock hits record after hepatitis C drug's success in Europe
 

Keywords :   


Gilead stock hits record after hepatitis C drug's success in Europe

2013-11-22 23:55:24| Biotech - Topix.net

Gilead Sciences said Friday that an advisory committee in the European Union is recommending that its hepatitis C drug Sovaldi receive marketing approval.

Tags: in stock record europe

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11 NEXT
23.11
23.11(Rawlings)
23.11 DVD2
23.11
23.11 US Orig LP The Soul Searchers Salt Of ~
23.11Switch SR SL LED 2
More »